| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 42626 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell) Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 1, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 69 6681 6259 711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01 |
||||||
| 42627 | Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.12.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens Buyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 1, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01 |
||||||
| 42628 | Germany – Pharmaceutical products – Abschluss von Vereinbarungen zur wirtschaftlichen Versorgung von Kontrastmitteln im Rahmen eines Open House Modells Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 1, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Camelia Weikl E-Mail: SSB_Ausschreibung@he.aok.de Telefon: +496966816251323 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01 |
||||||
| 42629 | Poland – Portable computers – Dostawa laptopów na rzecz sądów powszechnych Buyer: Centrum Zakupów dla Sądownictwa Instytucja Gospodarki Budżetowej reprezentująca Sąd Apelacyjny w Krakowie | Notice type: cn... | Tender Procurement Contract | Poland | Not provided on the source page. Please check the official source. | Open Oct 2, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Centrum Zakupów dla Sądownictwa Instytucja Gospodarki Budżetowej reprezentująca Sąd Apelacyjny w Krakowie | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-10-02 |
||||||
| 42630 | France – Repair and maintenance services of medical equipment – GCS UniHA - Maintenance en Imagerie Médicale (MAINTIM 2020) SAD Buyer: GCS UniHA | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-10-03 | Tender Procurement Contract | France | Not provided on the source page. Please check the official source. | Open Oct 3, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: GCS UniHA | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-10-03 |
||||||
| 42631 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Allergenextrakte aus Gräserpollen zur sublingualen Anwendung, Handelsbezeichnung Oralair(R), ATC V01AA02 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 3, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 |
||||||
| 42632 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Risankizumab, ATC L04AC18 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 3, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 |
||||||
| 42633 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Natalizumab in der Darreichungsform Konz.z.Herst.e.Inf.-Lsg. , ATC L04AG03 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 3, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 |
||||||
| 42634 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Pegfilgrastim, ATC L03AA13 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 3, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 |
||||||
| 42635 | BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) This funding announcement, issued by the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, seeks... | Grant Mixed | United States | Not provided on the source page. Please check the official source. | Open Oct 4, 2027 Open | Grants.gov |
|
Source description
This funding announcement, issued by the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, seeks transformative, cutting-edge, and innovative research that embraces new technologies, ideas, and approaches to understand brain circuit function and contributions to behavior. It is a component of the BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS) Program, which aims to lay the scientific foundation for the next generation of neural circuit-based approaches for preventing and treating devastating brain disorders.This Notice of Funding Opportunity (NOFO) supports Specialized Projects to develop current or emerging technologies to generate comprehensive atlases of brain connectivity, with an emphasis on human, non-human primate (NHP), and mouse. Projects using other species are also permitted, if their use is well justified and the goal is to test and validate approaches that can be generalized across species. Applications may address any aspect(s) of brain connectivity and associated data pipelines, including data collection, reconstruction, analysis, integration, dissemination, and interpretation, to enable faster, more precise, and more cost-effective generation and interpretation of brain-wide wiring diagrams. Funded projects will be integrated into the BRAIN CONNECTS Network consisting of projects funded under this and preceding BRAIN CONNECTS NOFOs, as a coordinated effort aimed at developing the capabilities to generate wiring diagrams that can span entire brains across multiple scales. |
||||||
| 42636 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-10 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42637 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Doravirin, ATC J05AG06 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42638 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Doravirin + Lamivudin + Tenofovirdisoproxilfumarat, ATC J05AR24 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42639 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Haloperidol (ausschließlich Injektionslösung), ATC N05AD01 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42640 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natalizumab (ausschl. in der Dafo. IFK), f. d. Zeit 01.12.25 - 30.11.26 (zzgl. Verlängerungsoption 1x12 Mon) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42641 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Infusionslösungskonzentrat), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42642 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Abirateron (ausschließlich 500 mg 90 Stück), ATC L02BX03 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42643 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Aflibercept (ausgenommen 114,3 mg/ml), ATC S01LA05 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42644 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Fertigspritze und Fertigpen), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42645 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Leuprorelin, ATC L02AE02 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42646 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Sumatriptan (ausgenommen Filmtabletten und Tabletten), ATC N02CC01 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42647 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-10 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Oct 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 |
||||||
| 42648 | Inclusive and climate resilient multimodal passenger hubs enhancing modal shift towards sustainable transport and shared mobility Expected Outcome:Project results are expected to contribute to all the following outcomes:Contribute to the objectives of the Clim... | Research Funding Cash Grant | Europe | Expected EU contribution: 9,000,000 EUR - 9,000,000 EUR | Open Oct 7, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to all the following outcomes:Contribute to the objectives of the Climate-Neutral and Smart Cities Mission by accelerating the transition towards climate neutrality targets in cities and reducing greenhouse gas and air pollutants emissions from transport due to the improved operation of the multimodal hubs.Reduce road congestion and improve air quality to protect health of citizens and urban biodiversity, by increasing shift towards sustainable and active modes of transport for city and intercity trips.Contribute to the objectives of the TEN-T Regulation by enhancing the climate resilience of multimodal passenger hub infrastructures and services in response to both the long-term effects of climate change and extreme weather eventsIncrease inclusivity, accessibility and improved experience for all passengers at multimodal hubs, b... |
||||||
| 42649 | Hydrogen cities Expected Outcome:A growing number of cities across Europe is developing hydrogen strategies, either for mobility applications or f... | Research Funding Cash Grant | Europe | Expected EU contribution: 5,000,000 EUR - 5,000,000 EUR | Open Oct 7, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:A growing number of cities across Europe is developing hydrogen strategies, either for mobility applications or for decarbonising their local and peri-urban industries and hard-to-abate sectors. By acting as experimentation and innovation hubs, these cities can be testbeds for the energy transition, balancing decarbonisation with competitiveness and social cohesion.Project results are expected to contribute to the following expected outcomes:Investments in - and deployment of - hydrogen applications and infrastructure for hard-to-abate sectors in and around cities to mitigate local air pollution and lead to economic growth and jobs, bringing urban environments at the forefront of sustainability and innovation.Communities of practice to foster the interaction between stakeholders from cities, ports, industry, local and regional government, as well as researchers and citiz... |
||||||
| 42650 | Enhancing Mobility for All: affordable, reliable, and accessible multimodal transport for inclusive rural and urban connectivity – Societal Readiness pilot Expected Outcome:Proposals should address all of the following outcomes:Strategies, best practices and innovative solutions are ma... | Research Funding Cash Grant | Europe | Expected EU contribution: 7,000,000 EUR - 7,000,000 EUR | Open Oct 7, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Proposals should address all of the following outcomes:Strategies, best practices and innovative solutions are made available to local authorities and actors to improve the availability, accessibility, and affordability of rural-urban transport and provide rural and urban populations in a vulnerable situation with better access to services and opportunities;Integrated multimodal solutions, which ensure seamless transitions between rural and urban transport modes improving first- and last-mile connectivity, are piloted and related implementation plans are developed for/by local authorities and transport operators;Responsiveness to a deeper understanding of the needs and concerns of diverse social group involved in or potentially affected by the R&I development, thereby increasing the potential for beneficial societal uptake, and building trust in results and outcomes. Dev... |
||||||